Gary Schaer to Male
This is a "connection" page, showing publications Gary Schaer has written about Male.
Connection Strength
0.382
-
Implementation of miRNAs to Reduce In-Stent Restenosis in the Future. J Am Coll Cardiol. 2015 Jun 02; 65(21):2328-30.
Score: 0.039
-
Adverse outcomes in hospitalized patients who develop ST-elevation myocardial infarction. Crit Pathw Cardiol. 2014 Jun; 13(2):62-5.
Score: 0.037
-
Clinical and angiographic outcomes of cardiac transplant patients treated with intracoronary beta-radiation for in-stent restenosis: a case series. Cardiovasc Radiat Med. 2004 Oct-Dec; 5(4):162-5.
Score: 0.019
-
Use of corticosteroids in the treatment of cholesterol crystal embolization after percutaneous transluminal coronary angioplasty and stent placement. J Invasive Cardiol. 2004 Apr; 16(4):222-3.
Score: 0.018
-
Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use. Cardiovasc Radiat Med. 2004 Jan-Mar; 5(1):9-14.
Score: 0.018
-
Correlates of failure following treatment with Sr-90 beta irradiation for in-stent restenosis. Catheter Cardiovasc Interv. 2003 Jun; 59(2):176-83.
Score: 0.017
-
Predictors of late cardiac events following treatment with Sr-90 beta-irradiation for instent restenosis. Cardiovasc Radiat Med. 2003 Jan-Mar; 4(1):7-11.
Score: 0.017
-
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. Eur Heart J. 2018 06 14; 39(23):2208-2216.
Score: 0.012
-
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. Circ Res. 2017 Jan 20; 120(2):324-331.
Score: 0.011
-
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina. JACC Cardiovasc Interv. 2016 08 08; 9(15):1576-85.
Score: 0.011
-
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. Circulation. 1996 Aug 01; 94(3):298-307.
Score: 0.011
-
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. Lancet. 2016 Jun 11; 387(10036):2412-21.
Score: 0.010
-
The ixCELL-DCM Trial: Rationale and Design. Cell Transplant. 2016; 25(9):1689-1699.
Score: 0.010
-
Effect of 100% oxygen administration on infarct size and left ventricular function in a canine model of myocardial infarction and reperfusion. Am Heart J. 1995 Nov; 130(5):957-65.
Score: 0.010
-
An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells: Role of MicroRNA-223 in Smooth Muscle Function and Atherogenesis. J Am Coll Cardiol. 2015 Jun 16; 65(23):2526-37.
Score: 0.010
-
Impact of a novel interventional platform and hospital design on the door-to-balloon time in patients presenting with ST-segment elevation myocardial infarction. Crit Pathw Cardiol. 2015 Mar; 14(1):39-43.
Score: 0.010
-
Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function. Circulation. 1994 Dec; 90(6):2964-75.
Score: 0.009
-
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. Am Heart J. 2013 Jun; 165(6):854-861.e2.
Score: 0.008
-
An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res. 2013 Mar 01; 112(5):816-25.
Score: 0.008
-
Achieving high quality in ST-segment elevation myocardial infarction care: one urban academic medical center experience. Crit Pathw Cardiol. 2012 Mar; 11(1):32-9.
Score: 0.008
-
Effect of cocaine on the coronary circulation and systemic hemodynamics in dogs. J Am Coll Cardiol. 1990 Nov; 16(6):1481-91.
Score: 0.007
-
Reduction in reperfusion injury by blood-free reperfusion after experimental myocardial infarction. J Am Coll Cardiol. 1990 May; 15(6):1385-93.
Score: 0.007
-
Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry. J Invasive Cardiol. 2010 Feb; 22(2):48-55.
Score: 0.007
-
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009 Dec 08; 54(24):2277-86.
Score: 0.007
-
Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med. 1985 Jun; 13(6):492-6.
Score: 0.005
-
Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patients. J Interv Cardiol. 2005 Feb; 18(1):27-31.
Score: 0.005
-
Clinical and angiographic profile of patients with markedly elevated coronary calcium scores (>or=1000) detected by electron beam computed tomography. Cardiovasc Radiat Med. 2004 Jul-Sep; 5(3):109-12.
Score: 0.005
-
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003 Nov 05; 290(17):2284-91.
Score: 0.004
-
Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts. Am J Cardiol. 2003 Aug 01; 92(3):312-4.
Score: 0.004
-
Aortic homograft endocarditis caused by Rhodotorula mucilaginosa. Infection. 2003 Jun; 31(3):181-3.
Score: 0.004
-
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002 Dec 04; 40(11):1928-34.
Score: 0.004
-
The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002 Jan 02; 39(1):30-6.
Score: 0.004
-
Clinical outcomes of patients treated with the cutting balloon and Sr-90 beta-irradiation for instent restenosis. Cardiovasc Radiat Med. 2002 Jan-Mar; 3(1):12-5.
Score: 0.004
-
Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation. 2001 Aug 14; 104(7):779-82.
Score: 0.004
-
Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet. 2000 Nov 18; 356(9243):1705-10.
Score: 0.004
-
Determinants of infarct size after thrombolytic treatment in acute myocardial infarction. Am J Cardiol. 1999 Jun 15; 83(12):1600-5.
Score: 0.003
-
Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s. Am J Cardiol. 1998 Jul 01; 82(1):43-9.
Score: 0.003
-
Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion. J Investig Med. 1996 Dec; 44(9):575-82.
Score: 0.003
-
Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1996 Oct 01; 78(7):747-50.
Score: 0.003
-
Excimer laser ablation before autoperfusion balloon inflation: a novel therapeutic approach to high grade stenoses in vessels supplying substantial myocardium at risk. Cathet Cardiovasc Diagn. 1992 Nov; 27(3):202-8.
Score: 0.002
-
The coronary circulation in human septic shock. Circulation. 1986 Apr; 73(4):637-44.
Score: 0.001
-
Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure. J Am Coll Cardiol. 1983 Apr; 1(4):1154-9.
Score: 0.001